Evidence map›Paper›PMID 30121625›Full record

ArticleGut2019

Alcohol inhibits T-cell glucose metabolism and hepatitis in ALDH2-deficient mice and humans: roles of acetaldehyde and glucocorticoids.

Yanhang Gao, Zhou Zhou, Tianyi Ren, Seung-Jin Kim, Yong He, Wonhyo Seo, Adrien Guillot, Yanhua Ding, Ruihong Wu, Shuang Shao and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Gut, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Alcohol-associated liver disease.The Journal of clinical investigation · 2024
    Review
  12. Alcohol metabolism in alcohol use disorder: a potential therapeutic target.Alcohol and alcoholism (Oxford, Oxfordshire) · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 2 countries.

Yanhang Gao *Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Zhou Zhou *Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Tianyi Ren *Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Seung-Jin KimLaboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Yong HeLaboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Wonhyo SeoLaboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Adrien GuillotLaboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Yanhua DingDepartment of Hepatology, First Affiliated Hospital, Jilin University, Changchun, China.
Ruihong WuDepartment of Hepatology, First Affiliated Hospital, Jilin University, Changchun, China.
Shuang ShaoDepartment of Hepatology, First Affiliated Hospital, Jilin University, Changchun, China.
Xiaomei WangDepartment of Hepatology, First Affiliated Hospital, Jilin University, Changchun, China.
Hong ZhangDepartment of Hepatology, First Affiliated Hospital, Jilin University, Changchun, China.
Wei WangLaboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Dechun FengLaboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Mingjiang XuLaboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Elaine HanLaboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Wei ZhongCenter for Translational Biomedical Research, University of North Carolina at Greensboro, Kannapolis, North Carolina, USA.
Zhanxiang ZhouCenter for Translational Biomedical Research, University of North Carolina at Greensboro, Kannapolis, North Carolina, USA.
Pal PacherLaboratory of Cardiovascular Physiology and Tissue Injury, National Institutes of Health/NIAAA, Bethesda, Maryland, USA.
Junqi NiuDepartment of Hepatology, First Affiliated Hospital, Jilin University, Changchun, China.
Bin GaoLaboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
National Institutes of Health · USNational Institute on Alcohol Abuse and Alcoholism · USFirst Hospital of Jilin University · CNJilin University · CNUniversity of North Carolina at Greensboro · US

Funding

UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ian Michael Carroll · 1999 to 2026
$31.6M
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injuryZIAAA000375 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI PACHER, PAL · 2009 to 2025
$27.8M
Pathogenesis and Novel Therapeutic Targets of Steatotic Liver Disease and CancerZIAAA000369 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI GAO, BIN · 2009 to 2025
$23.4M
NIDDK NIH HHS P30 DK056350
6 · The paper itself

Abstract

objectiveAldehyde dehydrogenase 2 (ALDH2), a key enzyme to detoxify acetaldehyde in the liver, exists in both active and inactive forms in humans. Individuals with inactive ALDH2 accumulate acetaldehyde after alcohol consumption. However, how acetaldehyde affects T-cell hepatitis remains unknown.

designWild-type (WT) and

resultsEthanol feeding exacerbated ConA-induced hepatitis in WT mice but surprisingly attenuated it in

conclusionsALDH2 deficiency is associated with elevated acetaldehyde and glucocorticoids post-alcohol consumption, thereby inhibiting T-cell activation and hepatitis.

Indexed as

Aldehyde Dehydrogenase, MitochondrialAnimalsBinge DrinkingConcanavalin ACorticosteroneDisease Models, AnimalEthanolGlucoseHepatitisHumansHydrocortisoneMiceT-LymphocytesAldehyde Dehydrogenase, MitochondrialConcanavalin ACorticosteroneEthanolGlucoseHydrocortisoneAKTbinge drinkingConcanavalin Aglucose metabolismglycolysisT-cell hepatitis

Identifiers

PMID30121625
PMCPMC6582747
OpenAlexW2886356454

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.